I. Boesl

发表

Thrombolysis with recombinant unglycosylated single-chain urokinase-type plasminogen activator (saruplase) in acute myocardial infarction: influence of heparin on early patency rate (LIMITS study). Liquemin in Myocardial Infarction During Thrombolysis With Saruplase.

J. Wójcik, J. Windeler, G. Hopkins, 1995, Journal of the American College of Cardiology.

Systematic review and network meta-analysis of the efficacy and safety of lidocaine 700 mg medicated plaster vs. pregabalin

J. Kleijnen, G. Worthy, S. Swift, 2019, Current medical research and opinion.

IMI2-PainCare-BioPain-RCT2 protocol: a randomized, double-blind, placebo-controlled, crossover, multicenter trial in healthy subjects to investigate the effects of lacosamide, pregabalin, and tapentadol on biomarkers of pain processing observed by non-invasive neurophysiological measurements of huma

A. Mouraux, R. Treede, I. Tracey, 2022, Trials.

Evaluation of the Population Pharmacokinetic Properties of Lidocaine and its Metabolites After Long-Term Multiple Applications of a Lidocaine Plaster in Post-Herpetic Neuralgia Patients

R. Bursi, D. Huntjens, C. Piana, 2017, European Journal of Drug Metabolism and Pharmacokinetics.

Lidocaine medicated plaster, an additional potential treatment option for localized post-surgical neuropathic pain: efficacy and safety results of a randomized, placebo-controlled trial

N. Attal, S. Koenig, I. Boesl, 2019, Current medical research and opinion.

Evaluation of the Population Pharmacokinetic Properties of Lidocaine and its Metabolites After Long-Term Multiple Applications of a Lidocaine Plaster in Post-Herpetic Neuralgia Patients

R. Bursi, D. Huntjens, C. Piana, 2017, European Journal of Drug Metabolism and Pharmacokinetics.

Efficacy and tolerability of a 5% lidocaine medicated plaster for the topical treatment of post-herpetic neuralgia: results of a long-term study.

R. Sabatowski, R. Baron, A. Binder, 2009, Current medical research and opinion.

Efficacy and tolerability of a 5% lidocaine medicated plaster for the topical treatment of post-herpetic neuralgia: results of a long-term study*

R. Sabatowski, R. Baron, A. Binder, 2009 .

IMI2-PainCare-BioPain-RCT3: a randomized, double-blind, placebo-controlled, crossover, multi-center trial in healthy subjects to investigate the effects of lacosamide, pregabalin, and tapentadol on biomarkers of pain processing observed by electroencephalography (EEG)

A. Mouraux, R. Treede, I. Tracey, 2021, Trials.

IMI2-PainCare-BioPain-RCT1: study protocol for a randomized, double-blind, placebo-controlled, crossover, multi-center trial in healthy subjects to investigate the effects of lacosamide, pregabalin, and tapentadol on biomarkers of pain processing observed by peripheral nerve excitability testing (NE

A. Mouraux, R. Treede, I. Tracey, 2022, Trials.